Ibandronic Acid
Therapeutic Group
Drugs For Treatment Of Bone DiseasesIndication Dosage
Reduction Of Bone Damage In Bone Metastases In Breast Cancer:
- Adult: 50 Mg Daily, Alternatively (by IV infusion) 6 Mg Every 3-4 Weeks
Hypercalcemia Of Malignancy:
By IV Infusion:
- Adult: 2-4 Mg As A Single Infusion, Dose To Be Adjusted According To Serum Calcium Concentration
Treatment Of Postmenopausal Osteoporosis:
- Adult (Female): 150 Mg Once A Month, Alternatively (by IV Injection) 3 Mg Every 3 Months, To Be Administered Over 15-30 Seconds.
- Children: Not Recommended.
Content
- Inj 2mg /6mg: Per ml: Ibandronic Acid 1mg: 2mg (2 ml Amp), 6mg (6 ml Vial).
- Inj 3mg: Per ml: Ibandronic Acid 1mg: 3 ml Pre-Filled Syringe.
- Tab 50mg /150mg: Ibandronic Acid 50mg /150mg
Pregnancy
Contraindicated In Pregnancy.
Stability
- Bisphosphonate
Contra Indications
- Hypersensitivity, Children, Hypocalcaemia, With Oral Use; Abnormalities Of The Oesophagus, Other Factors Which Delay Emptying (e.g. Stricture Or Achalasia)
Precautions
- Hypersensitivity, Children, Hypocalcaemia, With Oral Use; Abnormalities Of The Oesophagus, Other Factors Which Delay Emptying (e.g. Stricture Or Achalasia)
Lactation
- Contraindicated
Side Effects
- Abdominal Pain
- Asthenia
- Bone Pain
- Chills
- Diarrhoea
- Dyspepsia
- Fever
- Gastritis
- Headache
- Hypocalcaemia
- Hypophosphataemia
- Influenza-like Symptoms
- Muscle Pain
- Nausea
- Pharyngitis
- Rash
- Vomiting
- Severe Oesophageal Reactions (discontinue).
- Rare: Anaemia
- Angioedema
- Atypical Femoral Fractures
- Bronchospasm
- Hypersensitivity Reactions
- Injection-site Reactions
- Pruritus
- Urticaria
- Osteonecrosis Of The Jaw